1. Alpha-synuclein in Parkinson's disease: a villain or tragic hero? A critical view of the formation of α-synuclein aggregates induced by dopamine metabolites and viral infection. (3rd April 2023) Authors: Carmo-Gonçalves, Phelippe; Coelho-Cerqueira, Eduardo; de Araujo Lima, Vanderlei; Follmer, Cristian Journal: Expert review of neurotherapeutics Issue: Volume 23:Number 4(2023) Page Start: 321 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Beyond Topoisomerase Inhibition: Antitumor 1, 4‐Naphthoquinones as Potential Inhibitors of Human Monoamine Oxidase. (April 2014) Authors: Coelho‐Cerqueira, Eduardo; Netz, Paulo A.; do Canto, Vanessa P.; Pinto, Angelo C.; Follmer, Cristian Journal: Chemical biology & drug design Issue: Volume 83:Number 4(2014:Apr.) Page Start: 401 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Conjugation with polyamines enhances the antitumor activity of naphthoquinones against human glioblastoma cells. Issue 6 (July 2018) Authors: Romão, Luciana; do Canto, Vanessa P.; Netz, Paulo A.; Moura-Neto, Vivaldo; Pinto, Ângelo C.; Follmer, Cristian Journal: Anti-cancer drugs Issue: Volume 29:Issue 6(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Gut Microbiome Imbalance and Neuroinflammation: Impact of COVID‐19 on Parkinson's Disease. Issue 9 (21st August 2020) Authors: Follmer, Cristian Journal: Movement disorders Issue: Volume 35:Issue 9(2020) Page Start: 1495 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Monoamine oxidase and α-synuclein as targets in Parkinson's disease therapy. (June 2014) Authors: Follmer, Cristian Journal: Expert review of neurotherapeutics Issue: Volume 14:Number 6(2014) Page Start: 703 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Monoamine oxidase and α-synuclein as targets in Parkinson's disease therapy. (June 2014) Authors: Follmer, Cristian Journal: Expert review of neurotherapeutics Issue: Volume 14:Number 6(2014) Page Start: 703 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The dopamine receptor agonist apomorphine stabilizes neurotoxic α‐synuclein oligomers. Issue 3 (29th December 2021) Authors: Lima, Vanderlei de Araujo; Esquinelato, Rodrigo; Carmo‐Gonçalves, Phelippe; Nascimento, Lucas Alex do; Lee, Hudson; Eliezer, David; Romão, Luciana; Follmer, Cristian Journal: FEBS letters Issue: Volume 596:Issue 3(2022) Page Start: 309 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. UV-induced selective oxidation of Met5 to Met-sulfoxide leads to the formation of neurotoxic fibril-incompetent α-synuclein oligomers. (September 2014) Authors: Carmo-Gonçalves, Phelippe; Pinheiro, Anderson S.; Romão, Luciana; Cortines, Juliana; Follmer, Cristian Journal: Amyloid Issue: Volume 21:Number 3(2014) Page Start: 163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Α‐Synuclein as an intrinsically disordered monomer – fact or artefact?. (2nd September 2013) Authors: Coelho‐Cerqueira, Eduardo; Carmo‐Gonçalves, Phelippe; Sá, Anderson; Cortines, Juliana; Follmer, Cristian Journal: FEBS journal Issue: Volume 280:Number 19(2013) Page Start: 4915 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗